ACRS - Aclaris Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ACRS is currently covered by 4 analysts with an average price target of $13. This is a potential upside of $9.6 (282.35%) from yesterday's end of day stock price of $3.4.

Aclaris Therapeutics's activity chart (see below) currently has 74 price targets and 97 ratings on display. The stock rating distribution of ACRS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.92% with an average time for these price targets to be met of 139.9 days.

Highest price target for ACRS is $16, Lowest price target is $10, average price target is $13.

Most recent stock forecast was given by BIREN AMIN from PIPER SANDLER on 05-May-2026. First documented stock forecast 02-Nov-2015.

Currently out of the existing stock ratings of ACRS, 8 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 05-May-2026

$11

$6.61 (150.57%)

$6

5 months 3 days ago
(05-May-2026)

1/2 (50%)

$6.25 (131.58%)

391

Buy Since 29-Nov-2016

$12

$7.61 (173.35%)

5 months 3 days ago
(05-May-2026)

0/2 (0%)

$7.25 (152.63%)

Buy Since 28-May-2025

$10

$5.61 (127.79%)

$8

5 months 9 days ago
(29-Apr-2026)

0/3 (0%)

$5.53 (123.71%)

Buy Since 14-May-2025

$16

$11 (220.00%)

$16

6 months 19 days ago
(19-Mar-2026)

0/11 (0%)

$12.26 (327.81%)

Buy Since 09-May-2025

$9

$4.61 (105.01%)

1 years 4 months 29 days ago
(09-May-2025)

1/12 (8.33%)

$7.74 (614.29%)

611

Show more analysts

Please expand the browser size to see the chart

What is ACRS (Aclaris Therapeutics) average time for price targets to be met?

On average it took 140 days for the stock forecasts to be reached, with an average price target met ratio of 22.92%.

Which analyst most recently updated their price target on ACRS (Aclaris Therapeutics)?

Biren Amin

Which analyst has the most public recommendations on ACRS (Aclaris Therapeutics)?

Biren Amin works at PIPER SANDLER and has 17 price targets and 14 ratings on ACRS

Which analyst is the currently most bullish on ACRS (Aclaris Therapeutics)?

David Steinberg with the highest potential upside of $27.61

Which analyst is the currently most reserved on ACRS (Aclaris Therapeutics)?

Alex Thompson with the lowest potential downside of -$3
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?